Form D · Other

ApniCure, Inc.

Redwood City, CA · CIK 0001583887

Offering snapshot reported Mar 17, 2016 · SEC filing

Reported sold
$15.8M
Offering amount: $17.4M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 2, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 17, 2016Initial$15,809,267No comparison10SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-259493
Sale and issuance of Common Stock, Series AA Preferred Stock and the underlying shares of Common Stock issuable upon the conversion thereof, and Warrants to purchase Series AA Preferred Stock.

Source: Form D, filed Mar 17, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Chris Daniel Executive
Glen French Director
Michael Mc Cullough Director
Jonathan Podmore Executive
John Stevens Director
Casey Tansey Director
Matthias Vaska Director, Executive
David White Executive
Phil Young Director

Issuer details

Industry: Other (See others in industry)

Address:
900 Chesapeake Drive
Redwood City, CA, 94063